Tara Bancroft
Stock Analyst at TD Cowen
(1.88)
# 1,781
Out of 4,479 analysts
6
Total ratings
75%
Success rate
46.22%
Average return
Main Sectors:
Top Industries:
4 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCUL Ocular Therapeutix | Upgrades: Buy | $7 → $11 | $6.68 | +64.67% | 3 | Jun 20, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $4.17 | +139.81% | 1 | Apr 29, 2024 | |
| MRUS Merus | Initiates: Outperform | n/a | $53.09 | - | 1 | Aug 21, 2023 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $19.81 | - | 1 | Aug 31, 2022 |
Ocular Therapeutix
Jun 20, 2024
Upgrades: Buy
Price Target: $7 → $11
Current: $6.68
Upside: +64.67%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $4.17
Upside: +139.81%
Merus
Aug 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $53.09
Upside: -
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $19.81
Upside: -